Clinical significance of NTRK family gene expression in neuroblastomas

The effect of P75 on Trk receptors in neuroblastomas

(2011) Ruth Ho et al.   CANCER LETTERS

The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan

(2010) Peter E. Zage et al.   CANCER

Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma

(2010) R. Iyer et al.   CLINICAL CANCER RESEARCH

The Studies on the Correlation for Gene Expression of Tyrosine-kinase Receptors and Vascular Endothelial Growth Factor in Human Neuroblastomas

(2010) Jihong Zhang et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis—a study of 106 primary neuroblastomas treated in a single institute

(2010) Tomoro Hishiki et al.   JOURNAL OF PEDIATRIC SURGERY

Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma

(2010) Daniela Raguer Valadão de Souza et al.   PEDIATRIC BLOOD & CANCER

c.1810C>T Polymorphism of NTRK1Gene is associated with reduced Survival in Neuroblastoma Patients

(2009) Beata S Lipska et al.   BMC CANCER

On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

(2009) C. J. Thiele et al.   CLINICAL CANCER RESEARCH

Trk Receptor Expression and Inhibition in Neuroblastomas

(2009) G. M. Brodeur et al.   CLINICAL CANCER RESEARCH